4//SEC Filing
Miller Joseph M 4
Accession 0001600620-24-000018
CIK 0001600620other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:27 PM ET
Size
5.1 KB
Accession
0001600620-24-000018
Insider Transaction Report
Form 4
Miller Joseph M
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-20+196,153→ 530,739 total
Footnotes (2)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,732 shares of common stock were acquired on May 31, 2023 and 1,742 shares of common stock were acquired on November 30, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001746372
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:27 PM ET
- Size
- 5.1 KB